Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs
- 18 May 2008
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Metabolism & Toxicology
- Vol. 4 (5) , 545-568
Abstract
Background: Biliary excretion is a major elimination route of many drugs and their metabolites. Hepatobiliary elimination is a vectorial process involving uptake transporters in the basolateral hepatocyte membrane, possibly Phase I and Phase II metabolizing enzymes, and ATP-dependent efflux pumps in the apical hepatocyte membrane. Objectives: Because many drugs and their metabolites are anions, this review focuses on transporters involved in their hepatocellular uptake (members of the organic anion transporting polypeptide (OATP) family) and biliary elimination (apical conjugate efflux pump ABCC2/MRP2). Methods: The molecular and functional characteristics of the human OATP and ABCC/MRP transporters are presented, including a detailed overview of endogenous and drug substrates. Examples illustrate the interplay of transporters with Phase II conjugating enzymes. Model systems to study the vectorial transport of organic anions are also discussed. Results/conclusions: OATP uptake transporters, conjugating enzymes, and ABCC2/MRP2 work in concert to enable the hepatobiliary elimination of anionic drugs and their metabolites. It is increasingly important to understand how genetic variants of these transporters and enzymes influence the interindividual variability of drug elimination.Keywords
This publication has 188 references indexed in Scilit:
- Characterization of Organic Anion Transporting Polypeptide 1b2-null Mice: Essential Role in Hepatic Uptake/Toxicity of Phalloidin and Microcystin-LRToxicological Sciences, 2008
- Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan‐pharmacokinetics and clinical outcome in patients with advanced non‐small cell lung cancerCancer, 2007
- Variability in human hepatic MRP4 expression: influence of cholestasis and genotypeThe Pharmacogenomics Journal, 2007
- Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemiaChemico-Biological Interactions, 2004
- Degeneration of an ATP-binding cassette transporter gene, ABCC13, in different mammalian lineagesGenomics, 2004
- Transport of bile acids in multidrug-resistance-protein 3-overexpressing cells co-transfected with the ileal Na+-dependent bile-acid transporterBiochemical Journal, 2003
- Catalog of 258 single-nucleotide polymorphisms (SNPs) in genes encoding three organic anion transporters, three organic anion-transporting polypeptides, and three NADH:ubiquinone oxidoreductase flavoproteinsJournal of Human Genetics, 2001
- Molecular Identification and Characterization of Novel Members of the Human Organic Anion Transporter (OATP) FamilyBiochemical and Biophysical Research Communications, 2000
- Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transportBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
- Adriamycin resistance in HL60 cells in the absence of detectable P-glycoproteinBiochemical and Biophysical Research Communications, 1987